Johnson & Johnson
I · AI-analyse
In het kort
J&J operates in two main areas: Innovative Medicine (prescription drugs for cancer, immunology, neuroscience, and other diseases) and MedTech (medical devices like surgical instruments, artificial joints, contact lenses under the ACUVUE brand, and robotic surgery systems) [Company Overview]. They sell to hospitals, doctors, pharmacies, and retailers worldwide [Company Overview].
Johnson & Johnson is a massive American healthcare company that makes both medicines (for cancer, immune diseases, etc.) and medical devices (surgical tools, contact lenses, artificial joints). With $96.4 billion in annual revenue and over 138,000 employees, it's one of the world's largest and most established healthcare firms [Company Overview].
Johnson & Johnson is in very strong financial shape with high profit margins and manageable debt.
Sentinellis-score
10/10
Financieel gezond
Marktkapitalisatie
$565,1B
Omzet (12 maanden)
$96,4B
Uitleg
Hoe wij deze cijfers lezen
Begrijpelijke gidsen · geen account nodig
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LezenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LezenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LezenII · Recent nieuws
Wat de koers bewoog
1 bericht · gesorteerd op relevantie
- Macro2026-04-16
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.7% – Time to Sell?
Ticker Report
Premium · gratis met elk account
The Piotroski score of 3 out of 9 is concerning — this metric measures financial strength trends, and a low score suggests weakening fundamentals or operational efficiency compared to prior periods, though the specific drivers are not detailed in the data [Sentinellis calculation].
Risico's
3
Kansen
3
Waarschuwingssignalen
2
Leiding
10
Nog 7 bevindingen in het volledige rapport — gratis met elk account.
Ontgrendel de volledige analyse van Johnson & Johnson
Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.
- 3 risico's, 3 kansen en 2 waarschuwingssignalen — elk met zijn bron
- Meer dan 100 financiële cijfers met grafieken en vergelijkingen
- Volledige nieuwssamenvattingen met bronlinks
- Directie en beloning
- PDF-export voor offline
III · Vergelijkbare bedrijven
Misschien ook interessant
Zelfde sector · Gezondheidszorg — of vergelijkbare financiële gezondheid
Op je volglijst zetten?